EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY-NC-ND 4.0

SPG4 Hereditary Spastic Paraplegia: From Etiology to Therapy

Emanuela Piermarini iD, Peter W Baas iD

Movement Disorders · 2026

DOI: 10.1002/mds.70453 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Movement Disorders, 2026. Verfasst von Emanuela Piermarini und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurobiology and Anatomy, Drexel University College of Medicine, Philadelphia, Pennsylvania, USA. Hauptthemen laut MEDLINE: Spastic Paraplegia, Hereditary, Spastin. Die Arbeit nennt 115 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Hereditary spastic paraplegias (HSPs) comprise a heterogeneous group of heritable neurodegenerative disorders resulting from mutations in a wide variety of genes. HSP locomotor symptoms include lower limb weakness and spasticity that arise from progressive degeneration of corticospinal axons projecting from the motor cortex to the distal spinal cord. Ensuing gait defects typically lead to wheelchair dependence. Degeneration of other tracts can also occur, expanding the constellation of symptoms to potentially include urinary, fecal, and speech problems, as well as intellectual disability. SPG4 ‐HSP, the most common variant, is caused by mutations in the SPAST gene, which encodes spastin, a microtubule‐severing protein with membrane‐related properties. Significant progress has been made in developing preclinical models for SPG4 ‐HSP and in elucidating its mechanistic etiology. On this basis, progress is being made on developing a flexible therapeutic regimen for patients at all stages of disease progression. © 2026 The Author(s). Movement Disorders published by Wiley Periodicals LLC on behalf of International Parkinson and Movement Disorder Society.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Spastic Paraplegia, HereditarySpastinHumansAnimalsMutationParaplegia

Stichwörter der Autor:innen

SPASTSPG4 Hereditary Spastic ParaplegiaType 4 Hereditary Spastic Paraplegiaantisense oligonucleotidescorticospinal tractsendoplasmic reticulumexercise therapygene therapyhereditary spastic paraplegiaintrabodiesmicrotubuleneurostimulationspastin

Substanzen

SpastinSPAST protein, human

Autor:innen und Institutionen

  • Department of Neurobiology and Anatomy, Drexel University College of Medicine, Philadelphia, Pennsylvania, USA.

ORCID-Profile: Emanuela Piermarini, Peter W Baas

Zitieren

APA

Piermarini, E., & Baas, P. W. (2026). SPG4 Hereditary Spastic Paraplegia: From Etiology to Therapy. Movement Disorders. https://doi.org/10.1002/mds.70453

Vancouver

Piermarini E, Baas PW. SPG4 Hereditary Spastic Paraplegia: From Etiology to Therapy. Movement Disorders. 2026. doi:10.1002/mds.70453

BibTeX
@article{Piermarini2026,
  author = {Piermarini, Emanuela and Baas, Peter W},
  title = {SPG4 Hereditary Spastic Paraplegia: From Etiology to Therapy},
  journal = {Movement Disorders},
  year = {2026},
  doi = {10.1002/mds.70453}
}
Kostenlos starten →